
Daniel Maspoch Comamala
New TechnologiesBachelor's degree in Chemical Sciences from the University of Girona (UdG) and Doctorate in Chemical Sciences Materials by the Autonomous University of Barcelona (UAB)/Institut de Ciència dels Materials of Barcelona (ICMAB-CSIC) Catalan Institute of Nanoscience and Nanotechnology (ICN2). Teacher of ICREA Research. Head of the NanoChemistry and Supramolecular Materials Group, Institute Catalan Nanoscience and Nanotechnology (ICN2). 187 publications (articles with review; + 6 book chapters). h-index: 55; quotes: 13290 (Google Scholar). 12 patent families. Graduates: 4 transferred to the industry. Signature of 4 technology transfer contracts with companies. Participation in 32 projects regional, national, European and international research, being coordinator or PI in 18. Signature of 22 projects with private funds through contracts with companies. Co-founder of the spin-off Ahead Therapeutics (2017). 3 products on the market: LuctaCaps®, co-developed with Lucta S.A.; Fungipol@CP, co-developed with Chemipol; and a product of the LipoferTM family, co-developed with Lipofoods-Lubrizo
Jury rulingThe New Technologies Jury of the King Jaume I Awards has decided unanimously award the award in its 2023 edition to Daniel Maspoch Comamala. With a successful balance between fundamental and applied research, his work focuses on the advancement of Nanotechnology and Chemistry for the design and development of Porous and Reticular Materials Substance Release Systems for different applications. In addition to its multiple patents, Maspoch has numerous contracts with the private sector to carry out its technology to the general public through new platforms. Specifically, the jury highlights its achievements in the administration of drugs, for the treatment of diseases such as diabetes, multiple sclerosis and muscular dystrophy; the development of technology biodegradable microencapsulation, in addition to its great dedication to personnel training researcher and talent attraction.
Click on his image if you want to see his extensive interview